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ANN   artificial neural networks 
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MT  magnetization transfer 
NOE  nuclear Overhauser effect 
RMSE  root mean squared error 
UHF   ultra-high field 
Abstract 
Purpose: Separation of different CEST signals in the Z-spectrum is a challenge especially at low field strengths 
where amide, amine, and NOE peaks coalesce with each other or with the water peak. The purpose of this work is 
to investigate if the information in 3T spectra can be extracted by a deep learning approach trained by 9.4T human 
brain target data. 
Methods: Highly-spectrally-resolved Z-spectra from the same volunteer were acquired by 3D-snapshot CEST MRI 
at 3 T and 9.4 T with similar saturation schemes. The volume-registered 3 T Z-spectra-stack was then used as input 
data for a 3-layer deep neural network with the volume-registered 9.4 T fitted parameter stack as target data. The 
neural network was optimized and applied to training data, to unseen data from a different volunteer, and as well to 
a tumor patient data set. 
Results: A useful neural net architecture could be found and verified in healthy volunteers. The principle gray-
/white matter contrast of the different CEST effects was predicted with only small deviations. The 9.4 T prediction 
was less noisy compared to the directly measured CEST maps, however at the cost of slightly lower tissue contrast. 
Application to a tumor patient measured at 3 T and 9.4 T revealed that tumorous tissue Z-spectra and corresponding 
hyper/hypo-intensities of different CEST effects can also be predicted.  
Conclusion: Deep learning might be a powerful tool for CEST data processing and deepCEST could bring the 
benefits and insights of the few ultra-high field sites to a broader clinical use. Vice versa deepCEST might help for 
determining which subjects are good candidates to measure additionally at UHF. 
  
Introduction 
Chemical exchange saturation transfer (CEST) allows for indirect detection of solute molecules via 
exchanging protons that transfer selectively applied saturation to the large water pool in tissue. While studies have 
been performed at clinical field strengths, CEST effects were always also studied at higher field strengths where 
peak separation and selective saturation is easier (1–4). Insights from ultra-high field (UHF) scans helped to identify 
the origin of the detectable insights at lower fields, such as the detection of nuclear Overhauser effects (NOE) 
upfield form water (4,5), creatine and protein contributions at 2 ppm downfield form water (6–10), or glutamate 
and amine contributions around 3 ppm downfield from water (11). Thus, the knowledge gained at ultra-high fields 
always helped the interpretation of clinical CEST contrasts.  
Some of the peaks can be detected separately only at ultra-high field and lead to the understanding that 
some signals detected at 3T are actually mixed signals from several resonances. The information is not gone, but 
just hard to extract, and 3T signals are still rich in information from different origins (12). The present article follows 
the approach of using prior UHF knowledge for 3T evaluation, in this case by applying artificial neural networks 
(ANNs) to combine these different data. The proposed neural network is trained using 3T Z-spectra as an input and 
9.4T CEST parameters as a target. Thus, it is trained to predict 9.4T CEST contrasts from a Z-spectrum measured 
at 3T. In a way, this is the most direct approach of using the 9.4T prior knowledge for 3T data evaluation.  
While application of neural networks in the field of MR has gained more and more interest in recent years 
(13–15), the presented approach represents a first step towards application in CEST MRI and is a rather simple 
approach. A multi-layer perceptron is used to combine co-registered data acquired at a 9.4T human scanner and a 
3T clinical scanner. The prediction is tested in a second healthy subject and as well in a brain tumor patient. The 
proof of concept demonstrated herein not only hints to a future of UHF-guided evaluation tools applicable to clinical 
data, but also immediately provides decision support for the question of which patients measured at 3T might benefit 
from a UHF CEST scan. The presented “deepCEST” approach not only gives insight into what information is 
hidden in the acquired 3T data, but also widens the perspective of UHF centers as potential prior-knowledge 
generators for many clinical sites. 
Methods 
Measurements were performed on 2 healthy subjects and on 1 patient with a brain tumor, with informed 
consent provided prior to the MRI experiments and under approval by the ethics committee of the medical faculty 
of the University Clinic, Tübingen Germany. All experiments were performed in accordance with relevant 
guidelines and regulations.  
 
9.4 T CEST MR imaging 
 9.4 T CEST imaging was performed on a whole body MRI system (Siemens Healthcare, Erlangen, 
Germany). A custom-built head coil  was used for signal transmission/reception (16 Tx/31 Rx channels) (16). The 
optimized 3D snapshot-CEST(17) acquisition consists of a pre-saturation module of 4.5 s followed by a readout 
module of duration TRO = 2.5 s, in which a train of RF and gradient spoiled gradient echoes with centric spiral 
reordering was acquired.  Imaging parameters were FOV=220x180x32 mm3, matrix size 144, 80% FOV in the first 
phase-encoding direction, thus, a phase-encoding matrix of 18x96 with phase encoding acceleration factor 3 and 
elliptical scanning; TE=1.85 ms, TR=3.64 ms, BW=700 Hz/px, 18 slices, FA=5° and elongation factor E=0.6 
(rectangular spiral reordered).  
The spectrally but not spatially selective CEST saturation period consists of a train of 150 Gaussian-shaped 
RF pulses, using a pulse duration of tpulse = 15 ms separated by pulse delay of tdelay = 15 ms, resulting in a total 
saturation time of Tsat = 4.5 s, and nominal B1 values of B1 = 0.6 µT, 0.9 µT, 1.2 µT. After the pulse train, a crusher 
gradient was applied to spoil residual transversal magnetization. Z-spectrum data was obtained after saturation at 
95 offsets in the range of ±50 ppm with denser sampling in the range of ±5 ppm (17) and normalized by unsaturated 
scans with 12s of relaxation and saturation at -300 ppm. After each acquisition a recovery time of Trec = 1.1 s takes 
place. Acquisition time per offset was TA= Trec +Tsat+TRO=8.1 s. For 95 offsets this yields a total scan time of 
approximately TAtot = 12 minutes for the total high-resolution CEST Z-spectrum scan. For CEST at three different 
B1 levels, plus B0 and B1 mapping using WASABI (18) and T1 mapping using a saturation recovery sequence, the 
total examination time of the highly-resolved CEST protocol was 40 minutes. During the patient scan, the CEST 
images were acquired at only two B1 levels due to limited scan time (B1 = 0.9 µT, and 1.2 µT).  
 
3 T CEST MR imaging 
CEST imaging at 3 T was performed on a whole body MRI system (PRISMA, Siemens Healthcare, 
Erlangen, Germany) on the same 2 healthy subjects and one patient. A similar 3D snapshot-CEST acquisition 
optimized for 3T consisted of a pre-saturation module of 4 s followed by a readout module of duration TRO = 3.5 s, 
in which a train of RF and gradient spoiled gradient echoes with centric spiral reordering was acquired.  Imaging 
parameters were FOV=220x180x48 mm3, matrix size 128, 80% FOV in the first phase-encoding direction, phase 
encoding acceleration factor 2 and elliptical scanning; TE=2 ms, TR=5 ms, BW=400 Hz/px, 18 slices, FA=6° and 
elongation factor E=0.5 (rectangular spiral reordered). 
The spectrally but not spatially selective CEST saturation period consists of a train of 80 Gaussian-shaped 
RF pulses, using a pulse duration of tpulse = 20 ms separated by pulse delay of tdelay = 20 ms, resulting in a total 
saturation time of Tsat = 3.6 s, and a single nominal B1 value of B1 = 0.6 µT. After the pulse train, a crusher gradient 
was applied to spoil residual transversal magnetization. Z-spectrum data was obtained after saturation at 56 offsets 
in the range of ±100 ppm with denser sampling in the range of ±5 ppm (17) and normalized by unsaturated scans 
with 12s of relaxation and saturation at -300 ppm. With B0 and B1 mapping using WASABI (18) and T1 mapping 
using a saturation recovery sequence, the total examination time for CEST at 3T was 10.5 minutes. 
 
Data evaluation 
Z-spectrum data was first corrected for motion using the AFNI’s 3Dvolreg function (19), followed by B0 
and B1 inhomogeneity correction using the WASABI approach (18), and the Z-3-point-B1-correction method (20) 
(images reconstructed at 0.5 μT for 9.4T).  Reference images are then manually masked to isolate CSF and brain 
tissues. CEST images were generated from the Z-value Z(Δω), given by the ratio of the saturated image Ssat(Δω) 
and the unsaturated image S0 
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To isolate CEST effects in the 9.4T Z-spectra from direct water saturation (spillover) and semi-solid magnetization 
transfer (ssMT), the five pool Lorentzian fitting method was used according to (21):  
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with the amplitude Ax, the full-width at half maximum Γx, and the chemical shift δx of the proton pool x relative to 
the water proton pool. Fit starting values and boundaries for each Lorentzian of this six-pool fit are given in the 
Supporting information including a description of how they were determined. Maps of each CEST peak refer then 
to the individual Lorentzian amplitude Ax in each pixel. Fitting was performed using least-squares optimization in 
MATLAB (R2016a, The Mathworks Inc, Natick, MA, USA) and took about 5 mins per 3D stack of Z-spectra.  
 
Neural networks architecture and training 
The principal artificial neural network architecture is a multi-layer perceptron as shown in Figure 1. We 
define the deepCEST network as a network where the input data is a 3T Z-spectrum and the output is a vector of 
Lorentzian fit parameters from Equation 3 obtained by an ultra-high field Z-spectrum fit. In Figure 1, each node 
represents a neuron, and each connection between the nodes represents a so-called layer weight. In a fully connected 
network as displayed here, the layer weights for each layer form a matrix LWij. The parameters in these matrices 
LWij are the free parameters of the neural network that are adjusted during the training process.  In the base 
implementation, the deepCEST network takes a 3T Z-spectrum with 45 offsets as input, yields 19 Lorentzian fit 
parameters as output, and has 3 layers and 400 neurons total, resulting in 54·100+100·200+200·100+100·19 = 
47300 free parameters.  
 
For a given input vector Z, the activations of the hidden layer Neurons are given by the following sigmoidal 
relations that are subsequently evaluated. 
A1 = tansig(b1 + ILW·Z)               (4) 
 
A2 = tansig(b2 + LW1·A1)              (5) 
 
A3 = tansig(b3 + LW2·A2)              (6) 
 
Where ILW are the initial layer weights, LW1, LW2 are hidden layer weights, b1, b2, b3 are additional bias 
neurons (bias neurons are not shown in Figure 1), and tansig is the activation function given by 
tansig(x)=2/(1+exp(-2x))-1             (7) 
 
The output is then given by the activations A3 and the so-called regression layer  
out = mapminmax(b4 + LW3·A3)             (8) 
 
where the function mapminmax is a linear function matching the interval [-1 1] to the range of the ouput data.  
  
 Figure 1: Scheme of the deepCEST network with an input 3T Z-spectrum (54 nodes) and output vector 19 
9.4T-Lorentzian-fit parameters in Equation 3.  This network consists of 3 layers with 100, 200, and 100 neurons, 
respectively. The free parameters of the network are illustrated by the green arrows that represent the layer weights. 
The deepCEST network with 3 layers and 400 neurons has 54·100+100·200+200·100+100·19 = 47300 free 
parameters.  
The training process is a so-called back-propagation optimization (scaled conjugate gradient 
backpropagation (22)) of the free parameters of the network using input 3T Z-spectra and target 9.4T parameter 
vectors of a training dataset. The starting point of the training uses randomly initialized matrices. To avoid 
overfitting, two strategies were employed. The first is early stopping. Here, the training data is randomly divided 
into a training set (70%), a validation set (15%) and a test set (15%), and the validation set is used to determine an 
early stopping criteria. If the root mean square error (rmse) of the validation data does not improve within 5 
iterations, the optimization is stopped. The second method is regularization, which uses a regularization factor γ to 
add a penalty to large weights and thus avoid overfitting. If mse is the mean-squared-error of the optimization 
and msw are the mean-squared-weights then the optimized function with regularization is 
msereg=γ∗msw+(1−γ)∗mse. In the final deepCEST network training, γ was set to 0.5. 
Input data of the deepCEST neural network are 3T Z-spectra of 54 frequency offsets, and the output or 
target data were the 19 Lorentzian fitting parameters of a 9.4T scan with 97 frequency offsets. Several neural 
networks were tested and are reported in the Supporting Information. The number of layers as well as the number 
of neurons in each layer was varied and optimized as well as the regularization factor γ  in the training procedure 
(see Supporting Figure S1).  The final architecture was chosen as a compromise between good performance and 
fast learning, leading to a regularization factor of γ =0.5 and a 3-layer-network with neurons in each layer given by 
[100 200 100] where this notation stands for [(neurons in input layer) (neurons in hidden layer) (neurons in output 
layer)].  
For training, data from only one volunteer was used. The second volunteer’s data as well as the tumor 
patient data were reserved for an independent test of the network. 
 
Results & Discussion 
Visualization of the trained neural network in action with layer weights and activations as given in 
Equations 4-8 is given in Figure 2. Please note, the layer weights are adjusted during training but constant for the 
trained net, and the activations depend on the specific input. Here we show the structure and parameters of the 
trained neural network together with its application to a 3T input Z-spectrum. The constant initial layer weights 
(Figure 2b) can be understood as filters applied to the Z-spectra to extract certain features. This initial layer shows 
some symmetric and asymmetric filters visibly highlighting features at direct saturation/semisolid-MT 
measurement indices. The hidden layer weights (Figure 2d,f) show the recombination of the initial gathered 
features. The output layer weights show that for each parameter, several features are used (Figure 2h). The output 
layer activations lead then to the output parameters employing a linear function (Eq. 9) displayed in Figure 2j. With 
these parameters and the Lorentzian function (Eq. 2-3) a predicted Z-spectrum can be calculated (solid red line, 
Figure 2a).  
After optimization of this neural network architecture (see Supporting Figure S1) a final network was 
trained and the training data set was analyzed (Figure 3). While predicted and real Z-spectra in three ROIs show a 
visual match (Figure 3 a-c), the prediction from the training dataset still shows small differences from the used 
target dataset, which are better visible in the parameter maps (Figure 3 d-g, h-k). Most obvious is the denoised 
appearance of the predicted data (Figure 3 h-k). For more quantitative insight, the difference between real and 
predicted contrasts was calculated (Figure 3, l-o). This reveals systematic changes e.g. in the CSF regions and also 
visible in the ROI evaluations (Figure 3, a-c).  
To analyze the dependencies of prediction mismatch of the neural network training, the exact same network 
architecture was trained with the same training data 10 times with different random starting weights. Figure 4 shows 
application of the 10 nets to the same data as in Figure 3.  ROI evaluations show that variation between different 
nets is small in tissue, with stronger deviations observed in CSF, also demonstrated by the higher standard deviation 
especially in CSF regions (Fig 4 q,r). The ssMT prediction shows to have the strongest standard deviations across 
networks. Still, the overall standard deviations of the training process are all below 1% and thus smaller than the 
deviation from the data. This means that the variability of the training process is much smaller than the variability 
of the output of a single trained net over the image. The mean prediction shows similar outcome as the single net in 
Figure 3. From this analysis, we can conclude that there are nets with better and worse predictions, and that CSF 
pixels can cause problems. An explanation for the variations of the trained nets in CSF could be the lower amount 
of CSF data, as well as pulsations and movement that are expected to be more severe in the CSF regions. The 
stronger deviations of the ssMT could be an interplay between the broad semi-solid line and the additional baseline 
constant used in the fit. However, observed differences also incorporate co-registration mismatches of the 3T and 
9.4T data and represent an upper limit of the network’s prediction errors. For the following evaluations, the mean 
network could be used, but to save computation time we decided for the network reflecting the closest match to the 
mean network outcome. 
In a next step, the trained network was applied to a completely new 3T dataset of a second volunteer to 
verify its generalization. Figure 5 shows the predicted data together with the additionally acquired 9.4T data. The 
measured data shows some regional artifacts that resulted from residual motion and B0 artifacts that could not be 
corrected for. Predicted amide and NOE contrast show the expected grey white matter contrast, but especially the 
amine CEST prediction shows reduced GM/WM contrast compared to the measured data and the training data set 
(Figure 3). CSF regions show deviations similar to those shown in Figure 3. Z-spectra are astonishingly similar in 
GM and WM tissues, but again the CSF ROI prediction as well as the overall ssMT estimation shows the largest 
deviations. 
A pixel wise-correlation of the whole test data (details summarized in Figure 8) set revealed strong 
correlation of the deepCEST prediction with the actual 9.4T data (R2=0.88) close to the R2 of the training data of 
0.95. Thus, we can conclude that the net trained on the data of a single volunteer not only performs well on training 
data, but is able to generally predict 9.4T contrast from 3T data with some loss in contrast.  At 9.4T, B0 and B1 
inhomogeneities are quite problematic and require correction that is already incorporated in the 9.4T data. Notably, 
the 9.4T maps predicted from 3T data have the nice B1 and B0 homogeneity features of the 3T scan. 
As an ultimate test for generalization of the deepCEST prediction ability, a tumor patient was scanned at 
both field strengths and the net, trained only on data from the first healthy subject, was applied to it. Figure 6 shows 
that the UHF CEST prediction in the tumor patient is comparable to the healthy test volunteer shown in Figure 5. 
In addition to healthy tissue contrast, tumor tissue contrast can also be predicted by the neural network: amide CEST 
shows hyper-intensity in the tumor area in both acquired 9.4T data as well as in the deepCEST prediction. Also, 
NOE-CEST and ssMT maps show clear decrease in the tumor area as well as a strong drop in the necrotic cyst as 
expected (21,23). At the boundaries of the cyst, the real data shows some highlights also observed in the prediction;  
these features are better visible in the zoomed image in Figure 7 a,b (black arrows). Figure 7c,d show the 2 ppm 
signal with a more narrow windowing, revealing similar hyperintensities in the tumor area when compared to 
contralateral tissue. However, some small regions are wrongly predicted (white arrows). It seems that CSF-like 
tissue is predicted as this region is also hypointense in the NOE prediction.  The 2 ppm signal might still be least 
reliably extracted from 3T data, as the resonance is strongly affected by direct water saturation at 3T. The regression 
analysis shows now even lower R2 of 0.83 and the predicted features are generally lower than those observed in the 
measured 9.4T data (see Figure 8c). 
The approach presented herein is not employing spatial information, but single voxel Z-spectral data. Thus 
the achieved spatial coherence in tissues in the test data sets is already an interesting result and a verification of the 
generality of the deepCEST nets. Also, in contrast to neural nets working on images that demand many brains and 
tumors to come into the big data regime, the voxel-frequency-based approach already has 200,000 input and target 
vectors in the 3D training data set of a single volunteer available for training. Moreover, while image based neural 
network approaches need to be trained with tumor data, we could show that a Z-spectrum based neural network 
trained with healthy data was also able to predict tumor Z-spectra and yield enhanced or depleted contrast similar 
to the real 9.4T scan. One could ask how the neural network can predict signals that it has never learned; however, 
this is equivalent to the question if tumor Z-spectra can be expressed as superposition of Z-spectra of different 
healthy tissues, which is more plausible. Thus, already with one or a few volunteer training data sets, a relatively 
general deepCEST network can be created. Of course, some patient datasets could be added to the training. 
However, we think it is beneficial to not do so: if patient data is added it can be argued that the net predicts tumors 
because they were in the training and the result is therefore biased. A neural network that predicts contrast in tumors 
but is only trained on healthy volunteers is therefore favorable. 
While the neural network functionality is not very transparent, the average gradient method as described in 
the Supporting Information can be used to gain insights into which frequency offsets the neural network is more 
sensitive to for each parameter determination.  The average gradient of the network is shown in Supporting Figure 
S2 and shows at least plausible offset sensitivities for both NOE and amide CEST effects with coarse correlation to 
the GM/WM difference Z-spectra. If the network would have disproportionately weighted a single offset to estimate 
the output parameters, such an offset would be visible in Figure S2. In principle, it is possible to further analyze the 
network to optimize the actual acquired data points. Thus, the deepCEST network is not only a useful tool for 
generating contrast, but also allows further insights into where the information is hidden at 3T.  
The deepCEST approach presented here is configured for low power Z-spectra that are dominated by protein 
signals. However, the principle approach can be translated to creatine, glutamate, or hydroxyl CEST measurements 
which were until now also most successful at UHF (6,7,11,24,25).  Finally, nothing besides an actual UHF scan can 
give the insight of an UHF scan. However, while the predicted contrasts cannot be used yet for clinical decision 
making, it could already be of use for the imaging diagnostician: if the predicted UHF deepCEST contrast shows 
interesting features, this information could be used to plan an actual UHF CEST scan for this patient.  
Conclusion 
Prior knowledge about CEST spectra gained at UHF can be elegantly translated to 3T scans by using a 
pretrained deepCEST neural network to extract CEST contrasts. Neural nets need to be complex enough to describe 
multi-pool Z-spectra, while reducing complexity by reducing neurons enables denoising features. Using spectral 
data from each voxel and training with one co-registered 3D data set from a healthy volunteer, the net already allows 
for sufficient generality to predict unseen subject data and even tumor Z-spectra. Thus, the proof of concept is given; 
still, some artifacts could be observed in the prediction, thus the approach must be carefully further optimized. 
While clinical application of this approach might be validated in the future, the deepCEST prediction can already 
help in the decision of which patient could benefit from an additional UHF CEST scan. 
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List of Figures 
 
Figure 2: Visualization of the trained deepCEST neural network application as given by Equations 4-8, with layer 
weights and neuron activations as given in Figure 1. The 3T input data (blue line (a)) is feed into the first layer of 
the neural net (b); please note that the x-axis corresponds to measurement number and not to the offset frequency. 
The layer weights of the initial layer (b) show the filters which the training process generated to filter the 3T-Z-
spectra, such that the specific 3T Z-spectrum in (a) yields the activation patter in (c) in  the 100 neurons of the initial 
layer. These neurons are sigmoidally connected to the second layer with 200 neurons with (d) showing the layer 
weights for each connection between the first and second layers. With the given input this yields to the activation 
of layer 2 shown in (e). Layer weights and activation of layer 3 are given in (f) and (g). Layer 3 is connected to the 
output layer (h) with activations given in (i) which is linearly connected (Eq. 9) to the output parameters for this 
input, shown in (j). With these output parameters the predicted Z-spectra (solid line in a) was calculated and is 
compared to the actual measured 9.4T Z-spectrum (black points in a).  
 
  
Figure 3: deepCEST network applied to one healthy subject training dataset. ROI evaluations (a-c), real 9.4T CEST 
fits (d-g), prediction of net (h-k), prediction difference from data (l-o), 
 Figure 4: Variation of network training analyzed using 10 trained nets applied to 3T training data. ROI evaluations 
(column 1, a-c), real 9.4T data (column 2, d-g), mean prediction of the 10 nets (column 3, h-k), mean prediction 
difference form data (column 4 l-o), and the standard deviation of the 10 predictions (p-s).  
 
 
 
 Figure 5: deepCEST application to test data from a second healthy subject. ROI evaluations (a-c), real 9.4 T data 
(d-g), prediction of net (h-k), prediction difference from data (l-o). 
 Figure 6: deepCEST application to subject with brain tumor test data. ROI evaluations (a-d), clinical contrasts 
(e,j,o), real 9.4T data (f-i), prediction of net (k-n), prediction difference from data (p-s). 
 
 Figure 7: (a,b) Zoomed version of subfigures (f) and (k) of Figure 6. (c,d) tighter windowed versions of figures (i) 
and (n) of Figure 6. Black arrows show the enhancement at the edge of the cyst visible in both prediction and real 
data. White arrows show an area that is predicted hypo intense, but measured hyper intense in the 2 ppm signal.  
 
 
Figure 8: Regression plots for amide, NOE and ssMT signals for training data (a), test data of healthy subject (b), 
test data of subject with brain tumor (c). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supporting information 
 
Figure S1: Performance (rmse) and number of iterations during training of different network architectures (a) and 
regularization fixed at γ=0.5, as well as for different regularization terms for the network [100 200 100] (d). Panels 
(b,c) and (e,f) show the corresponding prediction of the amide CEST(b,e) and NOE CEST contrast (c,f) together 
with the real data (leftmost images).   
 
Optimization of the neural network architecture (Figure S1 a-c), and regularization (Figure S1 d-f) shows that 3 
layers yield the lowest root-mean-squared-error (rmse). The regularization yields good results for γ>=0.3. Thus, we 
choose 0.5 as a compromise for stronger penalty for high weights to achieve better generality. Both more neurons 
and lower regularization lead to an effectively higher number of free parameters which then allow the network to 
fit noise patterns in the training data, which can be observed as the noise in the predicted amide-CEST and NOE-
CEST maps (figure S1 b,c and e,f). Thus, by limiting the effective number of parameters, denoising and 
generalization can be achieved. The used regularization factor of 0.5 and layer structure with neurons given by [100 
200 100] seems to be a good compromise between performance, generalization, and denoising. 
 
 
Figure S2: Network analysis by average gradient δP/δZ(Δω) for the trained deepCEST network and N=M=40. 
Displayed are the amplitudes of the amide CEST and the NOE CEST peaks(a,b). Difference spectrum of grey and 
white matter (c,d). (a,c) zoomed out spectra, (b,d) zoomed in the range of -12 to 12 ppm.  
  
 
As a neural network is highly non-linear, a simple gradient calculation is not accurate according to 
(ftp://ftp.sas.com/pub/neural/importance.html). Thus δP/δZ(Δω), where P is the output parameter and Z is the input 
Z spectrum value, is estimated by evaluating many random input data with alterations of each individual offset. 
Pseudocode of this calculation is given below. δP/δZ(Δω) is a matrix of size (number of output parameters × number 
of input offsets) and yields the average sensitivity of each parameter as a function of each offset Z-value: 
 Pseudo-code for calculation of average gradient 
Z0 = list of all training data Z-spectra; 
nn=1; 
 
for kk=1:N 
    Z1=Z0(:,random_index);   % get N random 3T-Z-spectra from the dataset 
    PZ1=net(Z1);            % get deepCEST prediction for this spectrum 
   
    for jj=1:M    % get M random variations of Z1  
        for ii=1:number_offsets % for each offset      
 
           Z2=Z1;                    % X2 refreshed in each iteration 
           Z2(ii)=Z2(ii)+ 0.1*randn; % Z2(dw_ii) varied normally distrib. 
 
           PZ2=net(Z2);             % get deepCEST prediction for altered spectrum 
 
     dPdZ(:,ii,nn)=(PZ2-PZ1)./(Z2-Z1);  % calculate difference quotient 
 
        end 
        nn=nn+1;   % nn sums ii and jj, iteration variable for different Z1 and varied Z1=Z2 
    end 
end 
 
δP/δZ(Δω)  = mean(dPdZ (:,:,nn),nn); %average_gradient over all N and M variations 
 
The average gradient for the used deepCEST network and N=M=40 is displayed in Figure S2 for the amide signal 
and the NOE signal.  Both gradients for NOE and amide amplitude show dependencies for all offsets of the Z-
spectrum. This is not surprising as a multi-Lorentzian fit also requires knowledge of the background signals to 
isolate selective effects. The overall shape of the gradients coarsely correlates (amide) or anti correlates (NOE) with 
the difference spectrum of grey and white matter (Figure S2c,d). The gradient δAamide/δZ(3.5ppm) is negative, 
meaning lower Z-values here lead to higher amide CEST effect and is thus plausible. The gradient 
δANOE/δZ(-3.5ppm) does not show strong dependence on the input and NOE is more determined by offsets between 
-6 ppm and -10 ppm. This behavior can be understood by looking at the difference spectrum of grey and white 
matter, which also shows stronger differences around -6 to -10 ppm compared to -3.5 ppm. At 0 ppm the amide 
gradient has a sign change from negative to positive, and the NOE gradient has a sign change from positive to 
negative. This can be understood as a B0 correction feature: the response of a slightly shifted direct water saturation 
line will average out. To summarize, at least some insight into the inner workings of the neural network can be 
gained, and plausible sensitivity patterns are also observed. More detailed analysis of such networks might help to 
identify the most important frequency offsets that should be measured. 
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